What's New in Objective Assessment and Treatment of Facial Hyperpigmentation?

Vanessa E. Molinar, Susan C. Taylor, Amit G. Pandya

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Facial hyperpigmentation is common and challenging to treat in darker-skinned populations. A Medline literature search of articles published up to October 2013 reporting the objective assessment of and/or treatment for melasma, postinflammatory hyperpigmentation, dermatosis papulosa nigra, lichen planus pigmentosus, and erythema dyschromicum perstans was reviewed. Objective assessment was only reported for melasma and postinflammatory hyperpigmentation. Furthermore, randomized controlled trial evidence was only reported for melasma. Although progress has been made, there is a need to develop more objective outcome measures and effective treatments for hyperpigmentation.

Original languageEnglish (US)
Pages (from-to)123-135
Number of pages13
JournalDermatologic Clinics
Volume32
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Hyperpigmentation
Melanosis
Lichen Planus
Erythema
Randomized Controlled Trials
Outcome Assessment (Health Care)
Population

Keywords

  • Dermatosis papulosa nigra
  • Erythema dyschromicum perstans
  • Lichen planus pigmentosus
  • Melasma
  • Objective assessment of pigmentation
  • Postinflammatory hyperpigmentation
  • Treatment

ASJC Scopus subject areas

  • Dermatology

Cite this

What's New in Objective Assessment and Treatment of Facial Hyperpigmentation? / Molinar, Vanessa E.; Taylor, Susan C.; Pandya, Amit G.

In: Dermatologic Clinics, Vol. 32, No. 2, 2014, p. 123-135.

Research output: Contribution to journalArticle

Molinar, Vanessa E. ; Taylor, Susan C. ; Pandya, Amit G. / What's New in Objective Assessment and Treatment of Facial Hyperpigmentation?. In: Dermatologic Clinics. 2014 ; Vol. 32, No. 2. pp. 123-135.
@article{bc66a9f578a14f4397a1aeac144da599,
title = "What's New in Objective Assessment and Treatment of Facial Hyperpigmentation?",
abstract = "Facial hyperpigmentation is common and challenging to treat in darker-skinned populations. A Medline literature search of articles published up to October 2013 reporting the objective assessment of and/or treatment for melasma, postinflammatory hyperpigmentation, dermatosis papulosa nigra, lichen planus pigmentosus, and erythema dyschromicum perstans was reviewed. Objective assessment was only reported for melasma and postinflammatory hyperpigmentation. Furthermore, randomized controlled trial evidence was only reported for melasma. Although progress has been made, there is a need to develop more objective outcome measures and effective treatments for hyperpigmentation.",
keywords = "Dermatosis papulosa nigra, Erythema dyschromicum perstans, Lichen planus pigmentosus, Melasma, Objective assessment of pigmentation, Postinflammatory hyperpigmentation, Treatment",
author = "Molinar, {Vanessa E.} and Taylor, {Susan C.} and Pandya, {Amit G.}",
year = "2014",
doi = "10.1016/j.det.2013.12.008",
language = "English (US)",
volume = "32",
pages = "123--135",
journal = "Dermatologic Clinics",
issn = "0733-8635",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - What's New in Objective Assessment and Treatment of Facial Hyperpigmentation?

AU - Molinar, Vanessa E.

AU - Taylor, Susan C.

AU - Pandya, Amit G.

PY - 2014

Y1 - 2014

N2 - Facial hyperpigmentation is common and challenging to treat in darker-skinned populations. A Medline literature search of articles published up to October 2013 reporting the objective assessment of and/or treatment for melasma, postinflammatory hyperpigmentation, dermatosis papulosa nigra, lichen planus pigmentosus, and erythema dyschromicum perstans was reviewed. Objective assessment was only reported for melasma and postinflammatory hyperpigmentation. Furthermore, randomized controlled trial evidence was only reported for melasma. Although progress has been made, there is a need to develop more objective outcome measures and effective treatments for hyperpigmentation.

AB - Facial hyperpigmentation is common and challenging to treat in darker-skinned populations. A Medline literature search of articles published up to October 2013 reporting the objective assessment of and/or treatment for melasma, postinflammatory hyperpigmentation, dermatosis papulosa nigra, lichen planus pigmentosus, and erythema dyschromicum perstans was reviewed. Objective assessment was only reported for melasma and postinflammatory hyperpigmentation. Furthermore, randomized controlled trial evidence was only reported for melasma. Although progress has been made, there is a need to develop more objective outcome measures and effective treatments for hyperpigmentation.

KW - Dermatosis papulosa nigra

KW - Erythema dyschromicum perstans

KW - Lichen planus pigmentosus

KW - Melasma

KW - Objective assessment of pigmentation

KW - Postinflammatory hyperpigmentation

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84897856192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897856192&partnerID=8YFLogxK

U2 - 10.1016/j.det.2013.12.008

DO - 10.1016/j.det.2013.12.008

M3 - Article

C2 - 24679999

AN - SCOPUS:84897856192

VL - 32

SP - 123

EP - 135

JO - Dermatologic Clinics

JF - Dermatologic Clinics

SN - 0733-8635

IS - 2

ER -